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Polychiorinated Biphenyl Levels in the
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Yoshito Masuda,3 Jos Mes, MaryWolff,5 Peter Furst,6
Christiane Furst,6 KrisWilson-Yang,7 and Beth Chisholm7
Polychlorinatedbiphenyls(PCBs)aresyntheticchemicals, manufacturedinvolumefromabout 1929tothe1970s. En-
vironmentalcontamination byPCMshasbeendocumentedinvarioussubstances,includinghunantissue. PCBshavebeen
measured inhumantissuebyavarietyofanalytical methods.PCBlevelshavebeenreportedasanapproximationoftotal
PCBcontentexpressedintermsofacommercialmixture,byidentificationandquantificationofchromatographicpeaks,
orby qualitative andquantitativecharacterization ofspecific congeners. Until recently, thecoplanarmono-ortho-and
di-orthosubstitutedPCBs, which areespecially toxicandpresent insignificantconcentration inhumansfromindustrial
countries, had notbeenmeasuredinhumantissues. Examplesofvarioustypesofcommonlyusedanalysesarepresented
ingeneral populationsubjectsandinpersonswhoexperiencedspecialexposureInthispaper,theusefulnessofPCBblood
determinationsfollowingpotential exposureisdemonstrated, andtheirapplicationinhealthstudiesisillustratedfrom
anumberofcasestudies. CoplanarPCB, mono-ortho-substituted anddi-ortho-substituted PCB levels inhumanblood
arepresentedandcomparedwithpolychlorinateddioxin(PCDD)andpolychlorinateddibenzofuran(PCDF)levelsinthe
U.S. population. Dioxintoxicequivalentsforthetwogroupsofchemicalsarecalculatedandcompared. Itisfoundthat
mono-ortho-substituted and,toalesserextent,coplanerPCBs,contributesubstantially todioxintoxicequivalents(fEq)
inbloodfromU.S. adults. Becauseofsubstantial PCBcontribution todioxintoxicequivalents, totaldionliketoxicity can
onlybedetennined ifdioxins,dibenzoturans,anddioxinlikePCBsaremeasured.Atthepresenttime,PCBsmaycontribute
moredioxinliketoxicity inhumantissuesthandodioxinsandfuransinhumantissuesfromthegeneral populationinthe
United States, and probably forotherindustrialized countries aswell.
Introduction
PCBs arepersistent, synthetic, lipophilic, toxicchemicalsthat
are currently ubiquitous environmental contaminants (1). Their
manufacture and distribution increased markedly beginning
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about 1929. Based on laboratory, wildlife, and some human
studies, their toxicity was later appreciated, and PCBs were
bannedfromproductionandnewuseintheUnitedStatesandin
othercountries(2). Humanhealthstudieshavebeenhampered
by difficulty in estimating actual intake as distinguished from
potentialexposureandincharacterizationandquantificationof
isomers. Levelsofthetoxiccoplanar, mono-ortho-substituted,
anddi-ortho-substituted PCBcongenershavenotbeenreported
inhumantissuesfromthegeneralpopulationorexposedpersons
fromthe United States until recently.
IntheUnitedStates, packedcolumnchromatography ofblood
or fat, followed by matching ofpeaks containing several PCB
isomers, with patterns reported as commercial PCB mixtures,
suchas Aroclor 1242 orAroclor 1260, was the usual approach
used formeasurementandreportingofPCBs inhumantissue.
Frequently,thedetectionlimitsevenforthistotalvaluewerequite
high, for example, 5-15 ppb in human serum at some
laboratories, whichmaybeabovethemeanlevel forthegeneral
population.
Packed-columnapproachescommonintheUnitedStatesare
beingreplacedbycapillary-columnmethodswiththeuseofPCBSCHECTERETAL.
standards, whichhaverecentlybecomewidelyavailable, toaid
in identification ofpeaks. It is only recently thatvalues for in-
dividual congeners have been reported by a small number of
laboratories, very few ofwhich are inthe United States.
Since the 209 possible PCB congeners vary considerably in
toxicityandinpersistenceinhumans, failuretoreportindividual
congeners presents atleasttwoproblems. In somecases, total
levels found in a potentially exposed person after an incident
may bewithin the "normal" range foragivenpopulation, but
because levelsbefore exposure werenotknown, itis impossi-
bletodeterminewhetherexposureandincreaseinbodyburden
did occur. This problem might be avoided ifcongeners with
longer half-lives were reportedand foundtobeelevated. Fur-
ther, it is now known that certain PCB mixtures and specific
PCBcongeners exertaneurotoxicaction(3-9). Iftheindividual
congeners arenotidentifiedandquantified, itisnotpossibleto
determine ifthere isanincrease inbody burden ofthose PCBs
that may be ofconcern for agiven health outcome.
Inhealth studies, whetherepidemiological orclinical, deter-
mination ofdose from exposure to PCBs in casesas well as in
controls isessential. Ifallormostofthetoxic PCBspresentare
notmeasured, theexposureestimatesarefarlessaccuratethan
wouldotherwisebethecase. Ifonemeasuresdioxinsanddiben-
zofurans inhumantissues, butnotthedioxinlikecoplanarPCBs
and mono-ortho-substituted PCBs, then only a portion ofthe
dioxinlike toxicchemicals arebeing measured. With measure-
ment only ofthe dioxins and dibenzofurans in human tissue,
clinical and epidemiological studies may well misclassify ex-
posure incasesandcontrols. Thismay, inpart, explainthecon-
flicting human health studies regarding these chemicals. We
recently begantomeasurecoplanar, mono-orthoanddi-ortho-
substituted PCBs when it was suggested that measurement of
dioxinsanddibenzofuransaloneresultedinamisclassification
of total dioxin toxicity; this in turn could lead to errors in
epidemiology studies.
Inthis paper, wereview selectedcasehistoriesfromour re-
cent workmeasuring humantissue PCBlevels, onoccasion in
conjunction with dioxin measurements, as ithasevolved over
the past decade. The studies wereperformed either to attempt
todetermine whether intakeoccurredafterpotential exposure
to PCBs, polychlorinated dibenzodioxins, orpolychlorinated
dibenzofurans ortodeterminebaselinelevelsforapopulation.
Table 1. ConcentrationofPCB(ppb,wholeblood)inthebloodof11 Yusho
patients and30controlstaken21 yearsafterexposure(14-16).
PCB no.'
A 66=2,4,3',4'-tetra-CB
B 118=2,4,5,3',4'-penta-CB
C 153=2,4,5,2',4',5'-hexa-CB
D 138=2,3,4,2',4'5'-hexa-CB
E 156=2,3,4,5,3',4'-hexa-CB
F 180=2,3,4,5,2',4',5'-hepta-CB
G 170=2,3,4,5,2',3'4'-hepta-CB
Sum ofPCBs
B/C % ratio
E/C % ratio
Yushopatients
(n=ll)
Average SD
0.20 0.17
0.14 0.07
2.36 1.34
1.48 0.94
1.20 1.02
0.93 0.70
0.57 0.48
6.9 4.7
5.8 5.1
50.9 76.4
Controls
(n=30)b
Average SD
0.07 0.07
0.11 0.02
0.65 0.14
0.28 0.06
0.10 0.02
0.27 0.04
0.11 0.01
1.6 .30
16.4 16.8
15.2 11.8
Despitethenowpreferredcongener-specificmethods, theolder
packed-column separation andmeasurementofPCBs haspro-
vedusefulinsomecasesfordocumentingactual intakefollow-
ingapotential exposure. Forhistorical reasons, this will be il-
lustrated also.
Methods
Human blood, plasma, or tissue was placed in chemically
cleancontainersandfrozenattemperaturesofatleast-20'Cun-
tilanalyzed. Theanalytictechniques arereferencedandwillnot
be repeatedhere (10-14).
Resultsand Discussion
Yusho Rice Oil Poisoning, Japan, 1968
Toillustratecurrentfindings fromtheYushoriceoilpoison-
ing incident of Fukuoka, Japan, where PCBs, PCDFs, and
PCDDs were ingested, Table 1 reports a total of6.9 ppb on a
wet-weight basis for the Yusho patients blood inthis series as
compared with 1.6 for the controls (15-17). These samples
werefromsickYushopatients, wherethericeoilcontamination
with PCBs, PCDFs and, to a lesser extent PCDDs, had
previously been documented by chemical measurement. The
samples were obtained 21 years afterexposureoccurred. The
B/Cratio(PCB 118 = 2,4,5,3',4'/PCB 153 = 2,4,5,2',4',5')
of5.8 intheYushopatients ischaracteristically lowerthanthe
controls, at 16.4, eventwodecadesaftertheirexposure. Itwas
found that the total amountofPCBs did not always have to be
high for illness to occur. This was previously reported by
Masudaandcolleagues soonaftertheexposure. It is currently
feltthatthePCDFsinthericeoilcontributedfarmoretoillness
thandidthePCBs. Atypical PCBpattern, ratio, andlevel was
found to be characteristic of this first reported major PCB
environmental poisoning.
Figure 1 graphically depicts mean PCB serum levels forthe
selectedtetrathroughheptachlorinated PCBsinbloodof11 pa-
tientsascomparedtothecontrolbloodfromthegeneralpopula-
tion. Thelevelsvarybycongener, althoughthetotalPCBlevel
is6.9ppbfortheYushopatientsand 1.6fortheJapanesecon-
trols, by the method used. For specific isomers, such as
2,4,5,3',4'-PeCB, levelsaresimilaratthistimeperiod, at0.11
and0.14ppb. Aspreviously noted, theblood specimens from
these Yusho victims were collected 21 years after exposure
whichoccurredin 1968,documentingthepersistence inhuman
tissueofcertain PCB congeners followinghigh exposures.
GuamPCBTransformerIncident, 1987
Table 2 compares whole-blood PCB congeners and ratios
fromnineGuamworkerswhowerepotentiallyexposedtoPCBs
afteraPCBtransformerincidentandsubsequentcleanupthatoc-
curredin 1987(17). Bloodwasobtained2yearsaftertheinci-
dent. Worker number 7 clearly has elevated congener levels
comparedtootherworkers, andhistotalPCBlevel,obtainedby
adding the measured congeners, is 14.01 ppb, whereas the
average for this group is 4.02. Moreover, a characteristic
Yusho-like B/C congenerratio, a low7.2 is noted, where the
aBallschniter and Zell IUPAC numbers (30).
'Controls are the mean ofthree samples ofpooled blood from 10 persons
fromFukuoka,Japan.
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FIGURE 1. Mean PCB levels in Yushopatients and Fukuoka controls, wet weight, ppb.
Table 2. Concentration ofPCB in blood ofGuam workers (wetweight pbb [141).
PCB no.a 1 2 3 4 5 6 7 8 9 Average SD
A66=2,4,3',4'-tetra-CB 0.14 0.09 0.14 0.12 0.27 0.93 1.33 0.09 0.21 0.37 0.42
B 188=2,4,5,3',4'-penta-CB 0.19 0.11 0.13 0.19 0.11 0.15 0.42 0.14 0.17 0.18 0.09
C 153=2,4,5,2',4',5'-hexa-CB 1.49 0.88 1.06 1.40 0.61 0.57 5.78 0.96 1.59 1.59 1.52
D 138=2,3,4,2',4',5'-hexa-CB 0.58 0.36 0.40 0.64 0.27 0.26 1.95 0.41 0.69 0.62 0.49
E 156=2,3,4,5,3',4,-hexta-CB 0.20 0.20 0.19 0.28 0.04 0.18 0.87 0.26 0.32 0.28 0.22
F 180=2,3,4,5,2',4',5'-hepta-CB 0.54 0.30 0.41 0.81 0.28 0.20 2.73 0.43 0.77 0.72 0.74
G l70=2,3,4,5,2',3',4'-hepta-CB 0.21 0.11 0.15 0.31 0.09 0.06 0.93 0.15 0.30 0.26 0.25
SumofPCBs 3.35 2.05 2.48 3.74 1.67 2.35 14.01 2.44 4.05 4.02 3.61
B/C % ratio 12.8 12.5 12.3 13.5 18.0 26.3 7.2 14.7 10.7 11.2 5.9
E/C % ratio 13.4 22.7 17.9 20.0 6.6 31.6 27.4 20.1 17.7 14.5
aBallschmiter and Zell's IUPAC numbers (30).
averagevalue is 11.2forthepotentiallyexposed workersinthis thetenlowestlevelsfoundin asecondseriesof200potentially
series. ThislowerB/Cratioisbelievedtobeduetoinductionof exposedGuamworkers. Thetotallevels wereobtainedby sum-
hepatic enzymescapableofmetabolizing theB congener, 2,4, mingtheindividual congenervalues. Clearly, evenwithouthav-
5,3',4'-penta-CB, morereadilythantheC congener, 2,4,5,2', ing previous general population PCB levels on Guam, the 10
4',5 '-hexa-CB. high levels are markedly above that ofothers potentially ex-
Figure 2 summarizes PCB findings from the same incident, posed, whichis consistentwithexposuretoandintakeofPCBs
using different analytic techniques (14). Because Guam is a in some ofthepotentially exposed workers.
remoteSouthPacificisland, nopreviousdata wereavailable on
general population levels ofPCBs, so the highest and lowest Binghamton, New York, PCB Transformer
PCBlevelsfrompotentiallyexposedworkers arecompared. As Fire Incident, 1981
noted intheprevious Guam series inTable2, oneworker in a
seriesofnineshowedelevationofspecific PCB congenersand Figure3 shows adifferentapproach tothe useofblood serum
totalPCBs. Here, thetenhighestPCBlevels arecomparedwith PCBmeasurementtoestablishactualexposureorincreasedbody
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FIGURE2. PCB blood levels of20workers after a PCB transformer incident in Guam (wet weight).
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FIGURE3. Serial serum PCB levels inexposed firefighter. PCBs reported as Aroclor 1254. PCB fire in 1981, in Binghamton, New York, State Office Building.
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burden inworkers whoarepotentially exposed. Levels reported
here in serumare from sevenfirefighters who were involved in
putting out a PCB transformer fire in Binghamton, New York,
in 1981. Thecapillary-column technique wasnotavailabletous
then, nor were the firefighters' PCB levels available before the
incident. Blood samples were obtained immediately after ex-
posure in these firefighters (within days after they put out the
PCB fire). Serum PCB levels were alsoobtainedapproximate-
ly 10 months later. These serial values documentadecrease in
PCB levels inthat 10-month periodforthese7 firefighters. Itis
also ofinterest to note that someofthe initial values are within
theusual rangefound inadultsinNewYork, whichis5 - 10ppb,
wet weight, in serum. Ifserial measurements hadnotbeenob-
tained, itwould havebeendifficulttodocument intakeofthese
chemicals from the incident. Also, ifthe blood had been col-
lectedonly 10monthsaftertheincident, serumPCBlevelswould
have provided no information documenting the intake ofPCBs
thatoccurred. Theseserialvaluesillustratethepossibility ofer-
ror inconcluding alackofexposure from onetissue PCB level
when not taken immediately afterexposure. Depending onthe
congeners, half-lives may vary from months to years (18,19).
U. S. Capacitor Explosion
andExposure ofChildren
Tissue PCB levels fromanother incidentareshowninFigure
4. ThisincidentinvolvedaPCBcapacitorexplosionintheUnited
States after which metal and insulator wrapping, impregnated
with PCBs, fell to the ground (11). A group ofchildren played
with these attractive wrappings and some experienced various
acutehealtheffects. Onedeveloped anallergic reactionand was
treated forrespiratory distress andoculardischargeatahospital
emergency room. Severalothersdevelopedrashesandpruritus.
Because the incident involved a capacitor rather than a trans-
former, lowerchlorinated biphenyls predominated in the mix-
ture. InFigure4, dataarepresentedforthreegroupsofchildren;
thosewithdirectexposure(skincontact), thosewithindirectex-
posure (contactwithdirect-contact childrenattimeofexposure),
and those with no exposure (i.e., siblings living in the same
household or friends). The PCBs are categorized as higher
chlorinated andlowerchlorinateddependingontheirretention
compared toDDT. Childrenwith noexposureweretestedonce
and found tohave 1.9 ppboflowerchlorinated PCBs (LPCBs)
and 2.4 ppb of higher chlorinated PCBs (HPCBs). For four
children with direct exposure, the LPCBs averaged 12.9 in
August, 9 inJanuary, and6.3 ppb inJuly, whereas the HPCBs
werefoundinitiallytobeonly2.6ppb, 2.1 inJanuary, andfinally
1.5ppb inJuly. Thedifferentlevelsandresponseovertimetothe
LPCBs is striking in the directly exposed group ofchildren.
PCB Congeners inHuman Tissues
PCB levels are usually reported from fat tissue or blood
specimens. Itisusefultorecognizethattheselevelsreflectbody
burden and arerelatedtolevelsinvarious targetorgansofcon-
cern, butarenotnecessarily identicalinleveltotheseorganson
either a wetweight orlipid basis. Table 3 summarizes autopsy
datafromtwopatients forvariousorgansreportedonbothawet
weightandlipidbasis(10). Certainorganshavegreateramounts
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FIGURE 4. Serial serumwith(A)lowerand(B)higherchlorinatedPCBlevelsin
threegroupsofvaryingdegreesofexposure. (Direct)haddirectexposure, skin
contact; (indirect) hadcontactwithdirect-contactchildren; (none)hadnocontact.
ofPCBs, and, asexpected, adiposetissue, followedbyliver, has
the highest levels of these lipophilic compounds, which are
metabolizedtoalargeextentbytheliver. Certaincongenerssuch
as 180 and 153 aretypically athigherlevels. In ourexperience
todate, differentorgansappeartopresentdifferentpatternsand
levelsnotbasedexclusivelyontheirlipidcontent. Becausefew
autopsieshavebeenperformedwithPCBmeasurements, itisnot
yet possible to generalize as to which congeners are found in
specific organs and how the levels and patterns compare with
blood and fat.
PCB Congeners inHumanMilk
fromVariousGeographical Regions
Figure 5 presents samples fromourrecenthumanmilkPCB
congenerdatafromvariouscountries: theUnitedStatesandGer-
many(North-RhineWestphalia)aretypicalheavilyindustrialized
western countries; Novosibirsk and Kachug, two cities in
Siberia, representremotecitiesinacountrythatisbeingrapidly
industrialized; Vietnam is composed of both the less-
153SCHECTER ETAL.
Table 3. Mean PCB isomer levels inhuman autopsy tissue from two patients from North America, 1980s (ppb, wet weight and lipid) (10).
Tissue
PCB isomer Intra-abdominal Subcutaneous' Adrenal Liver Kidney Muscle Spleen
no.' Wet Lipid Wet Lipid Wet Lipid Wet Lipid Wet Lipid Wet Lipid Wet Lipid
28 2.25 3 4.3 5.3 2.2 7.3 0.55 3.5 0.25 6.9 0.85 11.0 1.55 63.9
52 1.3 1.7 1.55 1.9 0.7 2.1 0.9 4.4 0.35 9.2 0.35 4.0 0.4 17.8
74 0.9 1.1 1.0 1.2 0.2 0.8 8.2 31.1 0.6 17.1 0.1 0.9 0.3 14.4
66 2.5 3.3 2.15 2.6 0.65 2.2 0.75 4.0 0.3 7.1 0.25 3.2 0.3 13.4
101 0.75 1.0 1.15 1.5 0.8 2.5 9.2 2.7 1.0 2.5 0.25 0.9 0.15 5.0
151 0.8 1.0 0.75 0.9 0.3 1.1 0.23 0.9 0.1 2.1 0.08 1.0 0.13 5.5
118 5.95 7.3 2.15 2.6 0.8 2.6 9.2 34.8 1.0 29.4 0.25 2.7 0.15 6.1
153 88.3 118.6 21.45 26.1 6.15 20.5 4.85 24.6 2.15 61.4 2.4 27.7 0.3 13.4
105 7.35 8.8 79.5 98.1 20.05 67 16.2 57.1 0.13 2.9 4.5 57.8 0.63 9.3
138 46.1 61.8 39.9 49.3 2.85 9.2 14.05 50.1 0.75 21.3 0.5 5.9 0.45 16.9
187 4.15 5.6 5.5 6.4 1.2 4.0 0.5 3.5 0.5 14.5 0.35 3.9 0.1 3.5
183 10.15 13.7 14.2 17.7 3.45 11.7 2.98 10.5 0.23 6.1 1.53 19.6 0.4 8.6
156 4.55 5.8 7.3 8.9 1.55 5.1 1.05 5.1 0.08 2.4 0.3 3.4 0.1 1.2
180 79.45 104.5 99.8 121.7 22.45 74.7 17.55 70.8 1.35 37.1 6.25 37.2 0.7 7.6
Sum ofPCBs 254.5 337.2 280.7 344.2 63.35 210.8 86.21 303.1 8.79 220 17.96 179.2 5.66 186.6
aNumbering systems according to Ballschmiter and Zell (30) and in order ofgas chromatographic elution. 28=2,4,4'; 52=2,2',5,5'; 74=2,4,4'5; 66=2,3',4,4';
101=2,2'4,5,5'; 151=2,2'3,5,5,6; 118=2,3 4,4'5; 153= 2,2'4,4'5,5'; 105=2,3,3A4,4'; l38=2,2'3,4,4'5'; 187=2,2',3,4'5,5,6; 183=2,2'3,4,4 5,6; 156=2,3,3'4,4 5;
180=2,2'3,4,4'5,5'
bSubcutaneous adipose or fat tissue.
Table4. Dioxin, dibenzofuran, andcoplanar PCB levels inselected Vietnam veterans from the Michigan Agent Orange study and in five controls
from a KansasCity, Missouri, blood bank (ppt, lipid).
Patient
Congener
2,3,7,8-TCDD
1,2,3,7,8-PeCDD
1,2,3,4,7,8-HxCDD
1,2,3,6,7,8-HxCDD
1,2,3,7,8,9-HxCDD
1,2,3,4,6,7,8-HpCDD
OCDD
2,3,7,8-TCDF
2,3,4,7,8-PeCDF
1,2,3,7,8-PeCDF
1,2,3,4,7,8-HxCDF
1,2,3,6,7,8-HxCDF
2,3,4,6,7,8-HxCDF
1,2,3,7,8,9-HxCDF
1,2,3,4,6,7,8-HpCDF
1,2,3,4,7,8,9-HpCDFI
OCDF
Non-ortho coplanar PCBs
77 =3,4,3',4'-TCB
126=3,4,5,3',4'-PeCB
169=3,4,5,3',4',5'-HxCB
Mono-ortho PCBs
28=2,4,4'-Tri
74=2,4,4',5-Tetra
105=2,3,3',4,4'-Penta
118=2,3',4,4',5-Penta
156=2,3,3',4,4',5-Hexa
Di-ortho PCBs
99=2,2',4,4',5-Penta
128=2,2'3,3',4,4'-Hexa
138=2,2',3,4,4',5'-Hexa
153=22 ',4,4',5,5'-Hexa
170=2,2',3,3',4,4',5-Hexa
180=2,2',3,4,4',5,5'-Hepta
183=2,2',3,4,4',5',6-Hepta
185=2,2',3,4,5,5',6-Hepta
187=2,2',3,4',5,5',6-Hepta
TEF #1109 #1111 #1117 #1107 #0493 #0500 #1102 #1103 Controls
I ND (14.1) 3.58 ND (2.59) 131 22.9 54.5 8.21 4.4 3.3
0.5 7.93 8.68 3.98 9.61 35.5 10.5 9.62 6.05 7.1
0.1 Oa oa oa oa 10.9 oa 5.75 oa
0.1 94.4 84.8 38.4 52.6 168 120 89.8 38.2 70.7
0.1 13.6 10.4 5.68 9.12 35.9 23.8 10.9 7.78 14.3
0.01 179 122 44.1 63.6 333 128 146 70.3 156
0.001 1410 829 316 368 1740 465 631 553 1180
0.1 6.65 0.865 7.32 2.88 7.27 3.71 ND 2.30 ND 1.37 NA
0.5 17.75 6.72 ND 4.52 7.81 26.6 9.75 6.18 4.68 6.9
0.05 8.6 0.945 2.72 ND 1.82 4.91 ND2.21 ND3.14 ND 1.66 NA
0.1 15.75 9.35 5.5 12.1 21.5 13.7 9.5 5.89 9.6
0.1 19.25 6.74 ND4.97 11.2 0b ob 9.5 4.76 NCb
0.1 19.25 2.37 5.41 6.56 7.38 7.86 7.90 3.77 NA
0.1 18.45 2.48 ND 6.09 ND6.82 ND6.8 ND7.94 ND 6.92 ND4.05 NA
0.01 22.4 18 17.1 15.7 29.9 25.8 18.2 15.5 20.9
0.01 20.75 2.85 ND 7.98 ND 8.85 ND 7.2 ND 8.45 ND4.8 ND4.72 NA
0.001 54.5 6.1 ND 19.9 ND 20.1 ND 17.5 ND 19.5 ND 10.7 ND 10.6 0
0.01
0.1
0.05
0.001
0.001
0.001
0.001
0.001
0.00002
0.00002
0.00002
0.00002
000
0OO00
D00002
000002
0.00002
160 22.1
54.1 38
46.4 41.3
209 51.4 82.7 168
33.8 77.9 432 39.8
31.2 34.3 98.6 48.6
1650 6650 1440 4060 6460
14900 10100 8580 29200 47000
3860 3850 3920 7600 30000
10100 9230 6890 31200 125000
5050 3430 4720 16100 24200
44.6 28.1
38 47.3
52.9 38.7
2100 9140
9280 14400
3000 3000
9180 10600
8700 10100
3060
4770
3340
7610
5760
3710 8460 5680 33200 54300 8050 5640 6120
3330 2900 3100 5100 12000 3000 3000 2220
12500 22000 17400 56000 102000 20800 20400 16900
24100 34300 29900 71400 123000 30000 32800 26900
7450 12200 14600 11600 20600 9240 12600 10300
21300 28000 40400 22400 48400 21200 24400 24600
1650 1010 2800 4560 8940 3000 3000 900
1650 2400 2800 3520 7360 3000 3000 2120
3410 8050 13000 9080 18100 4820 6240 5400
28.6
42
30.7
7860
10800
1500
12700
7020
6990
1500
16100
25400
7840
19000
1500
1500
3500
Abbreviations: CDD, chlorinateddibenzodioxin; CDF, chlorinateddibenzofuran; T, tetra; Pe, penta; Hx, hexa; Hp, hepta; 0, octa; ND, notdetected; NA,
notavailable; NC, notcalculated (halfofthedetection limitused forcalculations). ajl,2,3,4,7,8- and 1,2,3,6,7,8-HxCDD, reported as 1,2,3,6,7,8-HxCDD.
bI,2,3,6,7,8 and2,3,4,6,7,8-HxCDF reported as2,3,4,6,7,8-HxCDF.
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PCB #153= 328
43%
PCB #180= 27 /
18%
PC0 #28= 2
0%
A_P 6B #180= 173
a_ 23%
PCB #138= 62
42%
Binghamton, N.Y., USA N=7
Sum of PCBs = 146 ppb
PCB #28- 16
7%
h PCB #180- 24
10%e
PCB #138- 99
43%
Novosibirsk, (USSR) N=i 0
Sum of PCBs = 229 ppb
PC0 #138= 257
34%
West Germany N=143
A Sum of PCBs = 760 ppb
PCB #153- 50
42% PCB #28- 7
6%
PCB #180- 13
11%
B
PCB #153= 24
41%
PC0 #138- 48
41%
Kachug, (USSR) N=4
Sum of PCBs - 118 ppb
PCB #153= 50
41%
PCB #180= 13
22%
PC6 #138-
31%
Hanoi, north Vietnam N=2
Sum of PCBs = 58 ppb
PCB #153= 9
39%
PCB #1 38- 7
30%
Thailand, Bangkok N=10
Sum of PCBs = 23 ppb
Da Nang & Dong Nal, south Vietnam N=22
C Sum of PCBs = 122 ppb
PCB #28= 3
13%
PCB #180= 4
17%
PC0 #138= 4
27%
PCB #153= 8
53%
Cambodia, Phnom Penh N=8
D Sum of PCBs = 15 ppb
FIGURE 5. PCBs in human milk from the general population (ppb, lipid). (A) Binghamton, New York, and WestGermany; PCB 52 and 101 are not detected. (B)
Novosibirsk and Kachug in Siberia; PCB 52 and 101 are < 2 ppb. (C) Hanoi, in North Vietnam, and Da Nang and Dong Nai, in South Vietnam; PCB 28, 52,
and 101 are not detected. (D) Bangkok, Thailand (PCB 52 and 101 are not detected) and Phnom Penh, Cambodia (PCB-28, 52, and 101 are not detected).
industrialized north and the more-industrialized south; Cam-
bodia is a nonindustrial country; and Thailand is a rural,
developing country beginning the process of industrialization
(20-22). The congeners measured are those we recently selec-
tively measured and reported intheWorld HealthOrganization
interlaboratory and field studiesofhuman milkand blood (23).
Althoughtotal levels arehigher in industrial and lower in less in-
dustrial countries, PCB 153 and 138 are seen to contribute
substantially in mostlocations. Because thepossibility exists that
PCBs can decrease neurobehavioral and cognitive ability in
PCB #153= 57
39%
PCB #153- 90
39%
PCB #138= .21
36%
PCB #180= 34
28%
PCB #180= 3
20%
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developing children, it seemsappropriate to measureindividual
congeners inmilkand blood, especially wheneffects onthefetus
and newborn areofconcern(3-7). Thesepatterns andlevels may
change markedly over time because PCBs are no longer pro-
duced, andtheirdisposal is being regulatedin manycountries.
The values presentedhereshouldbeconsideredonly illustrative
ofthe current values in these countries.
Mono-ortho-, Di-ortho-, and Coplanar PCBs in
HumanTissue: MichiganVietnamVeteransStudy
Ofconsiderable interestare recent reportsofthetoxiccoplanar
PCB congeners in human tissue at relatively high levels com-
pared todioxins anddibenzofurans (24-27). We wereconcerned
that by reporting dioxin and dibenzofuran congenersand PCBs
otherthancoplanarand mono-ortho-substitutedPCBs inhuman
tissue, we might beunderestimating total dioxinlike chemicals
and their toxicity in humans from industrial countries. We were
also concerned thatthis lackofinformationmightbeproducing
misleading estimates of such toxicity, thus causing major
methodological problems in human health studies concerning
dioxin, or, forthatmatter, PCBexposure. Therefore, weincluded
all measurable PCBsin a MichiganAgentOrangeBloodDioxin
PilotStudy inaddition tothe dioxins anddibenzofurans. There
is no reasonto supposethatthe50 U.S. Vietnam veterans inthis
study would have any special exposureto PCBs orwoulddiffer
fromotherMichiganresidents oralaboratorypooledbloodcon-
trol sample from KansasCity, Missouri, residents. Ofconcern
forthe Vietnam veterans was elevated2,3,7,8-TCDDfromAgent
Orange exposure(20yearspreviously) andtotaldioxintoxicity.
Our findings are presented in Table4. We measuredthedioxins,
dibenzofurans, non-ortho- coplanar PCBs,3,4,3 4'-TCB (PCB
77), 3,4,5,3 4'-PCB (PCB 126), 3,4,5,3'4'5 '-HCB (PCB 169),
and mono-ortho-substituted and di-ortho-substituted PCBs.
Table 4 shows the actual levels for each congener measured.
TCDD levels ranged from not detected to 131 ppt, suggesting
elevationofTCDD fromAgentOrangein someoftheseVietnam
veterans. Blood TCDD for the general U.S. population ranges
from 3 to 6 ppt. Patients 1107, 0493, and0500 areclearly above
the average, withTCDDlevelsof131,22.9, and54.5ppt, respec-
tively. ForthePCBs, thedi-ortho- congeners werepresentinthe
largest amount, with levels ranging from900 to 123,00 ppt.
Table 5 presentstotal levels, toxicequivalents(TEq), andper-
cent contribution for each type of compound. Total dioxins
ranged from409to 1712 ppt, thefuransfrom44to203 ppt. The
total coplanar non-ortho PCBs ranged from 101 to613 ppt, the
total mono-ortho PCBs 24,540 to232,660 pptandthetotal di-
orthoPCBs from79,100 to394,700ppt. There is aratioof1:143
for total dioxins and dibenzofurans to total measured PCBS.
Using theestimated PCBtoxicequivalency factorsproposedby
Safe(18)andthecurrentinternational dioxintoxicequivalency
factors (TEF) (28,29), wefoundmono-ortho-substituted PCBs
inwholebloodofadultMichiganmales tocontribute asignifi-
cantportionofthetotaldioxintoxicequivalents. ThetotalTEq
for the mono-ortho PCBs ranges from 24.5 to 232.7 and
contributes25-62% ofthetotalPCDD/FsplusPCBsTEqinthis
group ofeight male Vietnam veterans and five controls. The
dioxinscontributetotallevelsfrom409to2335pptandtotalTEq
rangingfrom8.5to 143. ThepercentcontributiontothetotalTEq
was between 18 and 61%, with TCDD alone contributing
ppt, lipid
0
* * * * * *
@ ~ %
0 0 0 t f
b e s
* v eBy We 1P Co
ppt, lipid
ppt, lipid
400
300
200
ETotal PCDD
OTotal PCDFs
ETotal Coplanar PCBs
ETotal Mono-ortho PCBs
OTotal DI-ortho PCBs
373
127126..
105 110 II
69 1kM~~~4
FIGURE 6. PCBs and dioxins inthe blood ofMichigan Vietnam veterans. (A)
Dioxin and dibenzofuran dioxin toxic equivalents, (B) PCB dioxin toxic
equivalents, (C)PCDD/F and PCBdioxintoxicequivalents.
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Table 5. Dioxin, dibenzofuran, and PCB levels, TEqs, and percentcontribution inselected Vietnam veterans fromtheMichigan
Agent Orangestudy andcontrols from aKansas City, Missouri, blood bankdonor pool (ppt, lipid).t
Patient no.
Congener
Total PCDDs
Total PCDFs
Total PCDD/Fs
Total non-ortho coplanar PCBs
Total mono-ortho PCBs
Total di-ortho PCBs
Total PCBs
Total PCDD/Fs and PCBs
Total PCDDs TEq
Total PCDFs TEq
Total PCDD/Fs TEq
Total non-ortho PCBs TEq
Total mono-ortho PCBs TEq
Total di-ortho PCBs TEq
Total PCBs TEq
Total PCDD/Fs and PCBs TEq
TCDD % contribution tototal
PCDD/Fs and PCBs TEq
Total PCDD % contribution to total
PCDD/Fs and PCBs TEq
Total PCDF % contribution to total
PCDD/Fs and PCBs TEq
Non-ortho PCBs % contribution to total
PCDD/Fs and PCBs TEq
Mono-ortho % contribution to
PCDD/Fs and PCBs TEq
Di-ortho % contribution to
PCDD/Fs and PCBs TEq
Total PCBs % contribution to total
PCDD/Fs and PCBs TEq
1109 1111 1117 1107 0493 0500 1102
1712
203
1915
261
35560
79100
114921
116836
25
17.7
42.7
9.3
35.6
1.6
46.5
89.2
1058
56
1115
101
33260
119320
152681
153796
19.5
5.8
25.3
6.1
33.36
2.4
41.7
67
409
56
465
274
25550
126880
152704
153169
8.5
3.5
11.9
7.03
25.6
2.5
35.1
47
634
72
706
164
88160
216860
305184
305889
143
7.4
150.4
10
88.2
4.3
102.5
253
2335
110
2445
613
232660
394700
627973
630418
66.1
17.4
83.5
49
232.7
7.9
289.5
373
833
76
909
256
30760
98610
12926
130535
77
7.7
84.7
8.1
30.8
2
40.8
125.6
896
61
956
136
47240
106580
153956
154912
25.2
6.1
31.3
6.9
45.7
2.1
54.8
86.1
1103 Controls
685
44
729
114
24540
95460
120114
120844
13.9
4.1
18
7
24.5
1.9
33.4
51.3
1431
37
1468
101
39880
83330
123311
124780
18.1
4.6
22.7
6
38.8
1.7
46.3
69.2
8 5 3 52 6 43 10 9 5
28 29 18 57 18 61 30 27 26
20 9 7 3 5 6 7 8 7
10 9 15 4 13 6 8 14 9
40 50 54 35 62 25 53 48 56
2 4 5 2 2 2 2 4 2
52 62 75 41 78 32 64 65 68
TEq, toxicity equivalents.
aControls and means ofn=percent contributions and totals are rounded.
3-52%, among this group where some persons had elevated
TCDDandothersdidnot. Thedibenzofurans' percentcontribu-
tion ranges from 3-20%, and non-ortho PCBs contribute be-
tween4and 15%, butthedi-ortho-substituted PCBs, whichcon-
tributedthemosttothemeasuredlevels, contributedonly2-5%
to the total TEq.
Figure 6 summarizes andgraphically presents the total TEq
values for nineteen ofthe Michigan veterans and also the Kan-
sas City, Missouri, pooled blood bank (n=5) whole-blood
laboratory controls, as well as the mean, minimum, and max-
imumlevels. Figure6A showsthetotalPCDD/FTEqlevelsrang-
ing from 12 to 150, with a mean of44. Figure 6Bpresents the
levels forthePCBsdioxintoxicequivalents(TEq). TheMissouri
controlshaveameanlevelof46, andthevaluesfortheveterans
(mean, 67) range from 35 to290, thelatter valuedocumenting
an exposure from an unknown source. From Figure 6C it is
possibletovisualizearatioofalmost 1:2forPCDD/Fs toPCBs
inthetotal TEq. Withthesefindings, itisprobablethathuman
health studiesconcerningthesepreviously unmeasured, highly
toxic PCBsmaybemakingseriousmisclassification errorsasto
exposureofcasesandcontrols. Clearly, usingcurrentestimates
ofdioxin TEqs, total dioxin toxicity is considerably higher in
the tissues of persons from the general population than was
previously thoughtto bethe case.
Conclusion
Inthe60yearssincelarge-scalePCBproductionbegan, PCBs
havebecomeofconcernbecauseoftheirtoxicityandtheamount
synthesized. Several analytic approaches have been used to
measure PCBs in human tissue. Each has its uses and its
drawbacks. AnalysisbypackedcolumnfortotalPCBs,presented
asanAroclormixtureapproximation, isrelativelyinexpensive,
at $75-$125 per analysis, and only 5-10 mLofwhole blood or
serumisrequired. Measurementofindividualcongenersusually
costs $300-$600 per analysis. If coplanar PCBs, ortho-
substituted PCBs, anddioxinsanddibenzofurans aremeasured,
costisusuallybetween$1,500and$3,000peranalysis. PCDD/F
analysis in human tissues usually costs $1,500-$2,500 per
analysis, andonlyaboutonedozenlaboratoriesqualifiedinare-
cent WHO interlaboratory PCDD/F and PCB blood and milk
validationstudy. Severalotherhighlycompetentlaboratoriesex-
ist, butworldwidecapacity isquitelimitedatpresent. Healthin-
surance usually does notpay for such monitoring because it is
currentlyconsideredexperimentaloraresearchtool. Workers'
compensationprogramsalsousuallydonotpay forPCBblood,
fatormilkanalyses, evenwhenexposureatworkandsubsequent
illness is in question.
It is apparent that PCB human tissue measurement is not a
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standard medicaltoolatthepresenttime. Thereisnoconsensus
astohowtoanalyzebloodforPCBs; whichcongenersareofim-
portancefordocumentationofintakeandforhealthconcernsor
whethertoreportvaluesonawetweightorlipidbasisforthese
lipid-soluble compounds. Whether whole blood, serum, or
plasma isbestforPCBmeasurementisanactivetopicofdiscus-
sion and to a large extent is still an openquestionbased on the
lack of data regarding correlation with body burden or target
tissue dose.
PCB human tissue analysis offers thepromiseofproviding a
useful tool in the practice ofmedicine (and possibly oflaw as
well) in suchareasasclinicalandepidemiologicalestimates of
exposure, which isessential forscientifically valid studies and
conclusions. Although the approaches we havedescribed here
have been very useful, a substantial amount ofwork remains
before PCBhumantissuemeasurementwillberoutine. Surpris-
ingly, althoughPCBmeasurement inhumantissuebeganearlier
thandioxin measurement, thefieldhas notadvancedasrapidly,
or as far, until recently.
Someofthestudieshere havebeenmadepossibleby thegenerousassistance
oftheChristopher Reynolds Foundation, the Samuel RubinFoundation, theCS
Fund, ChurchWorld Service, theterritoryofGuam, andtheStateofMichigan.
Theexperttechnical assistance inpreparationofthis manuscriptisdueto Ruth
Stento, KaranCharles, DeborahSuess, andDiannYannantuono. Mostofall, we
thank the patients whose blood and other tissues were used inthese studies.
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